News

In a July 9 memo, the director of the FDA's Center for Biologics Evaluation and Research contended there was not enough ...
Novavax's growth relies on Sanofi royalties and COVID/flu vaccines, lacking innovation and clear catalysts. Click here to ...
Moderna stock jumps 4.5% as the FDA grants full approval for its COVID-19 vaccine in high-risk individuals aged six months to ...
Pfizer's COVID vaccine (Comirnaty) is fully approved for patients ages 12 and up, and authorized for kids ages 6 months ...
The approval comes amid regulatory upheaval under HHS head Robert F. Kennedy Jr., who has pushed for changes around mRNA ...
The tightened approach ties in with the FDA's recent approval of Novavax's recently approved Nuvaxovid shot, which has only been cleared for this older, more vulnerable age group rather than for ...